Medical Weight Loss in Houston, TX

We use FDA-approved GLP-1 and GIP/GLP-1 receptor agonists — specifically semaglutide (Wegovy/Ozempic-class) and tirzepatide (Zepbound/Mounjaro-class). All medications are sourced from fully accredited US-based 503A compounding pharmacies, ensuring pharmaceutical-grade purity, exact concentrations, and absolute sterility.

Semaglutide is a single-receptor GLP-1 agonist — one of the most clinically studied weight-loss medications available, with an average 15% body weight reduction in trials. Tirzepatide is a dual-receptor agonist (GLP-1 + GIP), the newer next-generation option, with an average 22.5% body weight reduction in Phase 3 trials. Your physician will recommend the best fit based on your labs, history, and goals.

Most patients qualify with a BMI of 27+ with a weight-related condition, or BMI 30+. We also accept patients for inflammation and body composition treatment upon physician review, even at lower BMIs. A free consultation is the best way to find out — your physician will review your health history, labs, and goals before recommending a protocol.

Microdosing is a physician-directed strategy that uses intentionally lower doses of GLP-1 medications to suppress systemic inflammation while preserving lean muscle mass. Unlike aggressive dosing that prioritizes rapid weight loss, microdosing shifts body composition — more muscle, less visceral fat — and produces fewer side effects. It's ideal for patients focused on long-term metabolic health, not just the number on the scale.

Clinical trials show average reductions of 15% body weight with semaglutide and 22.5% with tirzepatide over 16–72 weeks. Individual results vary based on starting weight, protocol, adherence, and lifestyle factors. Our microdosing approach prioritizes body composition change alongside total weight loss — so the results hold longer after treatment ends.

The induction phase is typically 16–24 weeks, during which doses are progressively titrated to your response. After reaching your target weight, we transition to a maintenance protocol designed to keep results durable. Some patients continue long-term; others taper off after building a strong metabolic foundation. Your physician guides this decision.

The most common side effects are nausea, fatigue, and mild GI discomfort — and they are dose-dependent. Our microdosing approach specifically reduces these by avoiding the rapid hormonal spikes that cause them. Most patients tolerate treatment well. Your physician monitors your response throughout and will adjust dosing if needed.

Yes. Medical weight loss therapy is generally a qualifying expense for HSA and FSA accounts. We recommend confirming with your plan administrator before your first consultation. We are a cash-pay practice and do not bill insurance directly, but we can provide documentation to support your HSA/FSA reimbursement claim.

We offer both. Our full in-clinic program includes InBody body composition scans, in-person physician consultations, and hands-on monitoring at our Houston Heights and Vintage Park locations. We also offer an at-home telehealth program for patients who prefer async evaluation, mail-order medication, and quarterly check-ins — using the same pharmaceutical-grade medications.

Reaching your goal weight is the beginning of maintenance, not the end of care. We design a transition protocol to help you taper safely while preserving the metabolic foundation you've built. This includes continued body composition monitoring, optional complementary therapies (NAD+, B12, lipotropics), and physician check-ins. Our goal is results that hold — not a rebound cycle.